Vista Apex Acquired by Behrman Capital
On April 10, Behrman Capital announced that it entered into an agreement to acquire Vista Apex. Vista Apex manufactures a variety of consumable dental products for preventative oral hygiene, endodontics and restorative dentistry, including RE-GEN™ Bioactive Bulk Fill Composite, a popular bulk fill, dual-cure methacrylate-based material formulated to allow clinicians to fill all classes of restorations without shrinkage. The company was founded in 1997. Behrman Capital, a private equity firm, has raised more than $3 billion since its formation in 1991. Healthcare services is one of the firm’s three industry focuses. It is based in New York City. This transaction is... Read More »
Johnson & Johnson to Acquire Shockwave Medical for $13.1 Billion
Johnson & Johnson announced on April 5 that it will acquire all outstanding shares of Shockwave Medical for $335 per share in cash, corresponding to an enterprise value of approximately $13.1 billion including cash acquired. Shockwave Medical is a cardiovascular medical device company changing how calcified cardiovascular disease is treated with intravascular lithotripsy (IVL). IVL safely uses sonic pressure waves to disrupt challenging calcified plaque, resulting in significantly improved patient outcomes. Shockwave has also recently acquired the Reducer, which is under clinical investigation in the United States and is CE Marked in Europe. By redistributing blood flow within the... Read More »
Halma Expands Health Tech Portfolio With a More Than $90 Million Acquisition
Halma plc has announced the acquisition of Rovers Medical Devices BV, marking a significant step in expanding its healthcare technology offerings and driving innovation. The company is being acquired for an initial cash consideration of €85 million (approximately $91.8 million USD), with additional payments of up to €6 million (about $6.5 million) pending future performance. Rovers Medical Devices BV is involved in the development, production and world-wide sales of medical devices with a focus on cell sampling devices. The company had a revenue of €12 million (about $13 million USD) for the 12 months ending December 31, 2023, according to the original deal press release. Halma is a global... Read More »
Haemonetics to Acquire Medical Device Company Attune Medical
Haemonetics Corporation announced on March 5 that it has entered into a definitive agreement to acquire privately-held Chicago-based Attune Medical. Under the terms of the agreement, Haemonetics will acquire Attune Medical for an upfront cash payment of $160 million at closing plus additional contingent consideration based on sales growth in the three years following the consummation of the transaction and the achievement of other milestones. Attune Medical is a provider of a medical device, the ensoETM® proactive esophageal cooling device, used to control the core temperature of the patient’s body. ensoETM is the only FDA-cleared temperature regulation device indicated for... Read More »
Halma Expands Health Tech Portfolio With Rovers Medical Devices
Halma plc announced on March 4 the acquisition of Rovers Medical Devices BV for an initial cash consideration of €85 million ($91.8 million USD), with additional payments of up to €6 million (about $6.5 million) pending future performance. The acquisition is expected to strengthen Halma’s market position by broadening its healthcare technology offerings. Rovers Medical Devices is involved in the development, production and world-wide sales of medical devices with a focus on cell sampling devices. The company had a revenue of €12 million (about $13 million USD) for the 12 months ending December 31, 2023, according to the original deal press release. Halma is a global group of... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
